183 related articles for article (PubMed ID: 20521379)
1. Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct.
Espino AM; Morales A; Delgado B; Rivera FM; Figueroa O; Suárez E
Ethn Dis; 2010; 20(1 Suppl 1):S1-17-23. PubMed ID: 20521379
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.
Rivera F; Espino AM
Exp Parasitol; 2016 Jan; 160():31-8. PubMed ID: 26632503
[TBL] [Abstract][Full Text] [Related]
3. The immune response of rats to vaccination with the cDNA or protein forms of the cysteine proteinase of Fasciola hepatica.
Wedrychowicz H; Lamparska M; Kesik M; Kotomski G; Mieszczanek J; Jedlina-Panasiuk L; Płucienniczak A
Vet Immunol Immunopathol; 2003 Jul; 94(1-2):83-93. PubMed ID: 12842614
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis.
Espino AM; Rivera F
Vet Parasitol; 2010 Apr; 169(1-2):82-92. PubMed ID: 20056331
[TBL] [Abstract][Full Text] [Related]
5. Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice.
Espino AM; Osuna A; Gil R; Hillyer GV
Exp Parasitol; 2005 Aug; 110(4):374-83. PubMed ID: 15907838
[TBL] [Abstract][Full Text] [Related]
6. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
[TBL] [Abstract][Full Text] [Related]
7. A novel Fasciola hepatica saposinlike recombinant protein with immunoprophylactic potential.
Espino AM; Hillyer GV
J Parasitol; 2004 Aug; 90(4):876-9. PubMed ID: 15357089
[TBL] [Abstract][Full Text] [Related]
8. Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.
Kesik-Brodacka M; Lipiec A; Kozak Ljunggren M; Jedlina L; Miedzinska K; Mikolajczak M; Plucienniczak A; Legocki AB; Wedrychowicz H
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005451. PubMed ID: 28333957
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14.
Almeida MS; Torloni H; Lee-Ho P; Vilar MM; Thaumaturgo N; Simpson AJ; Tendler M
Parasite Immunol; 2003 Mar; 25(3):135-7. PubMed ID: 12911521
[TBL] [Abstract][Full Text] [Related]
10. Development of Two FhSAP2 Recombinant-Based Assays for Immunodiagnosis of Human Chronic Fascioliasis.
Shin SH; Hsu A; Chastain HM; Cruz LA; Elder ES; Sapp SG; McAuliffe I; Espino AM; Handali S
Am J Trop Med Hyg; 2016 Oct; 95(4):852-855. PubMed ID: 27549636
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and localization of saposin-like protein 2 of Fasciola hepatica.
Cabán-Hernández K; Espino AM
Acta Trop; 2013 Dec; 128(3):591-7. PubMed ID: 23988299
[TBL] [Abstract][Full Text] [Related]
12. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
[TBL] [Abstract][Full Text] [Related]
13. Vaccine potential of recombinant saposin-like protein 2 against Fasciolosis gigantica in mice.
Kueakhai P; Changklungmoa N; Riengrojpitak S; Chaichanasak P; Meemon K; Chaithirayanon K; Chantree P; Sansri V; Itagaki T; Sobhon P
Vaccine; 2013 Nov; 31(47):5518-23. PubMed ID: 24075921
[TBL] [Abstract][Full Text] [Related]
14. Fasciola hepatica: an antigen fraction derived from newly excysted juveniles, containing an immunoreactive 32-kDa protein, induces strong protective immunity in rats.
van Milligen FJ; Cornelissen JB; Bokhout BA
Exp Parasitol; 2000 Mar; 94(3):163-71. PubMed ID: 10831381
[TBL] [Abstract][Full Text] [Related]
15. Induction of immunity in mice to Fasciola hepatica with a Fasciola/Schistosoma cross-reactive defined immunity antigen.
Hillyer GV
Am J Trop Med Hyg; 1985 Nov; 34(6):1127-31. PubMed ID: 3834796
[TBL] [Abstract][Full Text] [Related]
16. Failure of a recombinant Schistosoma bovis-derived glutathione S-transferase to protect cattle against experimental Fasciola hepatica infection.
De Bont J; Claerebout E; Riveau G; Schacht AM; Smets K; Conder G; Brake DA; Capron A; Vercruysse J
Vet Parasitol; 2003 Apr; 113(2):135-44. PubMed ID: 12695038
[TBL] [Abstract][Full Text] [Related]
17. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
[TBL] [Abstract][Full Text] [Related]
18. Humoral responses in mice following vaccination with DNA encoding glutathione S-transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression.
Smooker PM; Steeper KR; Drew DR; Strugnell RA; Spithill TW
Parasite Immunol; 1999 Jul; 21(7):357-64. PubMed ID: 10417670
[TBL] [Abstract][Full Text] [Related]
19. Intranasal delivery of a formulation containing stage-specific recombinant proteins of Fasciola hepatica cathepsin L5 and cathepsin B2 triggers an anti-fecundity effect and an adjuvant-mediated reduction in fluke burden in sheep.
Norbury LJ; Basałaj K; Zawistowska-Deniziak A; Sielicka A; Wilkowski P; Wesołowska A; Smooker PM; Wędrychowicz H
Vet Parasitol; 2018 Jul; 258():14-23. PubMed ID: 30105973
[TBL] [Abstract][Full Text] [Related]
20. A Vaccine Based on Kunitz-Type Molecule Confers Protection Against
Silvane L; Celias DP; Romagnoli PA; Maletto BA; Sanchez Vallecillo MF; Chiapello LS; Palma SD; Allemandi DA; Sanabria REF; Pruzzo CI; Motrán CC; Cervi L
Front Immunol; 2020; 11():2087. PubMed ID: 33193292
[No Abstract] [Full Text] [Related]
[Next] [New Search]
